ATAZANAVIR SULFATE 300 MG CAP

Atazanavir
$2.7319per EA

Strength

300 mg/1

NDC

65862071330

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ATAZANAVIR SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA204806

On Market Since

6/25/2018

Pharmacological Classes

Cytochrome P450 2C8 Inhibitors
Cytochrome P450 3A Inhibitors
Cytochrome P450 3A4 Inhibitors
HIV Protease Inhibitors
Protease Inhibitor
UDP Glucuronosyltransferases Inhibitors
UGT1A1 Inhibitors

Price History

1W

0.0%

1M

+1.3%

3M

+1.4%

6M

-2.1%

1Y

-21.0%

3Y

-21.6%

5Y

-70.9%

All

-90.0%